Consolidated Statement of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023
Cash flows from operating activities:
Net increase (decrease) in net assets resulting from operations	$ 23,060
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net unrealized (appreciation) depreciation on investments	(7,960)
Net unrealized (appreciation) depreciation on foreign currency forward contracts	(141)
Net realized (gain) loss on investments	(181)
Payment-in-kind interest capitalized	(113)
Net accretion of discount and amortization of premium	(820)
Amortization of deferred financing costs	247
Amortization of deferred offering costs	486
Purchases of investments	(346,141)
Proceeds from sale of investments and principal repayments	18,697
Changes in operating assets and liabilities:
Interest receivable	(9,815)
Receivable for investments sold	(870)
Payable for investments purchased	194,923
Interest payable	6,357
Trustees fees payable	(92)
Accrued expenses and other liabilities	3,600
Net cash provided by (used in) operating activities	(118,763)
Cash flows from financing activities:
Borrowings of debt	80,100
Repayments of debt	0
Payments of financing costs	(6,267)
Payments of offering costs	(2,080)
Proceeds from issuance of common shares	179,500
Distributions paid in cash	(4,580)
Net cash provided by (used in) financing activities	246,673
Net increase (decrease) in cash, cash equivalents and restricted cash	127,910
Cash, cash equivalents and restricted cash, beginning of period	19,486
Cash, cash equivalents and restricted cash, end of period	147,396
Supplemental information and non-cash activities:
Interest paid during the period	1,612
Borrowing of debt from in-kind contribution	272,530
Purchases of investments from in-kind contribution	(521,356)
Proceeds from issuance of common shares from in-kind contribution	248,826
Distributions declared and payable	$ 2,290